Early Phase Leader Avance Clinical dominates early phase CRO in Australia with rapid ethics approvals, no IND requirement, and a 43.5% R&D tax rebate, enabling sponsors to accelerate timelines and reduce upfront costs.

Oncology Center Expansion Acquisition of LumaBridge and creation of an oncology center of excellence positions Avance to support global oncology programs across the US and Australia, enabling multi region trials and cross border capabilities for sponsor pipelines.

Strategic Partnerships Partnership with Calidi Biotherapeutics demonstrates credibility in advanced modalities and gene targeted therapies, signaling appetite to collaborate on high potential assets and expand into genetically focused programs.

Center of Excellence Appointment of Liahna Toy as senior vice president and head of early phase center of excellence reinforces a strong leadership team focused on accelerating high quality early phase trials, improving sponsor engagement.

Global Footprint A broad geographic footprint across New Zealand, Asia, North America, and Europe enables sponsors to run multi region trials through a single CRO partner, simplifying coordination, regulatory alignment, and logistics while accessing diverse patient populations.